Learn about common triggers for rheumatoid arthritis flares, including environmental, physiological, and emotional factors, ...

Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

GLP-1 receptor agonists, particularly new generation agents such as semaglutide and tirzepatide, may significantly reduce the ...

Injured victims of a bus crash rest after receiving initial treatment at a hospital, in Dana Sar, a remote area near the border of Balochistan and Khyber Pakhtunkhwa provinces, in ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

Impact and progress Frontiers' impact Our annual reports Thought leadership ...

Correspondence to Professor Alicja Wolk, Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Box 210, Stockholm 171 77, Sweden; Alicja.Wolk{at}ki.se ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Will we finally leave the past behind and make progress on prevention?

Periodontitis remains a major global health challenge, but better outcomes depend on consensus in diagnosis, collaboration ...